Clinical Trial Update: Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety study evaluating CD3/CD19 depleted haploidentical stem cell transplants in pediatric patients with acute leukemia, aplastic anemia, and child…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Leukemia
• Solid Tumors

Drugs mentioned

• CD3/CD19-depleted haploidentical stem cell product (CD3/CD19-depleted haploidentical stem cells)

Snippet

Sponsor: University Children's Hospital Tuebingen | Conditions: Acute Leukemias, Aplastic Anemia | Phase 1, Phase 2 | Status: UNKNOWN